Pasithea Therapeutics Corp Warrant 2021-12.08.26 on Pasithea TherapeuticsPasithea Therapeutics Corp Warrant 2021-12.08.26 on Pasithea TherapeuticsPasithea Therapeutics Corp Warrant 2021-12.08.26 on Pasithea Therapeutics

Pasithea Therapeutics Corp Warrant 2021-12.08.26 on Pasithea Therapeutics

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪10.94 M‬USD
−5.0824USD
‪−13.90 M‬USD
0.00USD
‪6.97 M‬
Beta (1Y)
6.41

About Pasithea Therapeutics Corp.


CEO
Tiago Reis Marques
Headquarters
Miami Beach
Founded
2020
ISIN
US70261F1113
FIGI
BBG01231TZF3
Pasithea Therapeutics Corp. is a biotechnology company focused on the research and discovery of new and treatments for psychiatric and neurological disorders. The company was founded by Yassine Bendiabdallah and Lawrence J. Steinman on May 12, 2020 and is headquartered in Miami Beach, FL.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Displays a symbol's price movements over previous years to identify recurring trends.